1216429-25-2

Basic information

• Product Name: AGN 193109-d7
• Synonyms: AGN 193109-d7;4-[2-[5,6-Dihydro-5,5-diMethyl-8-(4-Methylphenyl-d7)-2-naphthalenyl]ethynyl]benzoic Acid;CD 3106-d7
• CAS NO: 1216429-25-2
• Molecular Formula: C28H24O2
• Molecular Weight: 392.48896
• Product Categories: Aromatics;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals
• Mol File: 1216429-25-2.mol
• Article Data: 0

Chemical Properties

• Melting Point: 276-296?C
• Appearance: /
• Storage Temp.: -20°C Freezer
• Solubility: DMSO, Methanol (Sparingly)
• CAS DataBase Reference: AGN 193109-d7(CAS DataBase Reference)
• NIST Chemistry Reference: AGN 193109-d7(1216429-25-2)
• EPA Substance Registry System: AGN 193109-d7(1216429-25-2)

Safety Data

• Hazardous Substances Data: 1216429-25-2(Hazardous Substances Data)

Usage

Description

AGN 193109-d7 is a labeled retinoic acid receptor (RAR) antagonist, which is an off-white solid. It is primarily used in the medical field to address the side effects associated with chemotherapy and radiation therapy.

Uses

Used in Medical Applications:
AGN 193109-d7 is used as a therapeutic agent for mitigating the side effects of chemotherapy and radiation therapy. Its role as a RAR antagonist allows it to counteract the negative impacts of these treatments, improving the overall patient experience and potentially enhancing the effectiveness of the therapies.
Used in Pharmaceutical Research:
In addition to its direct application in medical treatments, AGN 193109-d7 is also utilized in pharmaceutical research. Its chemical properties and RAR antagonist activity make it a valuable compound for studying the mechanisms of action and potential interactions with other drugs, contributing to the development of novel therapeutic strategies and drug delivery systems.